Home MassBio panel tackles why rare disease treatments cost so much
 

Keywords :   


MassBio panel tackles why rare disease treatments cost so much

2013-03-17 19:52:04| Biotech - Topix.net

David Meeker, right, CEO of Genzyme Corp., speaks at a panel on pricing of rare disease therapies at the MassBio annual meeting.

Tags: cost panel disease rare

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.11
25.1124cm
25.11! CDBest
25.1110
25.11 Y0385
25.11101138
25.11SideM Blu-ray
25.11 15th Anniversary CD & DVD BOX CLAMPAZAR
More »